News &amp; Updates

Patients with congenital heart disease-associated pulmonary artery hypertension (CHD-PAH) have favourable midterm outcomes, a new study reports.

Good midterm outcomes seen in congenital heart disease-related PAH

Hormone combination helps short teens become taller

In teens with short stature, the combination of gonadotropin releasing hormone analogue (GnRHa) and recombinant human growth hormone (rhGH) yields a significant increase in adult height, as shown in a study.

Hormone combination helps short teens become taller

Risk-stratified testing at SGH reduced COVID-19 transmission

A risk-stratified testing strategy employed at Singapore General Hospital (SGH) helped minimize disruption to surgical procedures during the COVID-19 pandemic and reduced virus transmission to healthcare workers (HCWs), a recent study showed.

Risk-stratified testing at SGH reduced COVID-19 transmission

Cardiovascular risk factors tied to hearing impairment in men

Men with cardiovascular risk factors, hypertension in particular, appear to be at a higher risk of hearing impairment (HI), reports a recent Japan study.

Cardiovascular risk factors tied to hearing impairment in men

Mepolizumab: Targeting eosinophils in severe asthma with precision medicine

Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.

Mepolizumab: Targeting eosinophils in severe asthma with precision medicine

High dose comparable to lower doses of ACE inhibitors for heart failure

In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.

High dose comparable to lower doses of ACE inhibitors for heart failure

Visual axis opacity common after IOL implantation in children

Visual axis opacity (VAO) frequently occurs following intraocular lens (IOL) implantation in early childhood, a recent study has found.

Visual axis opacity common after IOL implantation in children

AI-enabled dashboard monitors visual loss in glaucoma

An artificial intelligence (AI) dashboard for examining glaucomatous functional loss, developed using a large visual field (VF) dataset containing a broad spectrum of visual deficit types, provides clinicians with a user-friendly tool to determine the severity of glaucomatous vision deficit and the spatial extent of the damage, as well as monitor disease progression, reports a study.

AI-enabled dashboard monitors visual loss in glaucoma

Use of 5α-reductase inhibitors does not affect Gleason grading

A recent study has found no significant impact of 5α-reductase inhibitors on Gleason grading, with no difference in mortality seen among users and nonusers in each Gleason group.

Use of 5α-reductase inhibitors does not affect Gleason grading

Can coronary plaque EVAPORATE with prescription-grade EPA?

The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.

Can coronary plaque EVAPORATE with prescription-grade EPA?